Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Switzerland
Page logo
Latest News

Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference
Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference

New Brunswick, NJ (January 27th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in Citi’s 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

  • Media Contacts
    Stephanie Hartgrove
    (732) 524-1941

    Investor Contacts
    Sarah Wood
    (732) 524-2617
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue